We report a novel strategy to fabricate metal nanoparticle/carbon nanotube hybrids with unique plasmon properties as well as biocompatibility and further apply them as efficient dark field light scattering agents for cancer cell imaging.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: